PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.\', \'Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.\', \'Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Québec, Canada.\', \'Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto and Women\'s College Hospital, Toronto, Ontario, Canada.\', \'Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis.\', \'Department of Psychiatry, School of Medicine, Washington University in St Louis, St Louis, Missouri.\', \'Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamanetworkopen.2022.6269
?:doi
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 35385087
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all